The effect of leukocyte-reduction method on the amount of human cytomegalovirus in blood products: A comparison of apheresis and filtration methods

Blood

Volumn 97, Issue 11, 2001, Pages 3640-3647

  Dumont, Larry J ^a,b,c,d,e,f   Luka, Janos ^a,b,c,d,e   Vandenbroeke, Tania ^a,b,c,d,e   Whitley, Pamella ^a,b,c,d,e   Ambruso, Daniel R ^a,b,c,d,e   Dean Elfath, M ^a,b,c,d,e  

^a Gambro BCT   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^d AMERICAN RED CROSS   (United States)

^e Bonfils Blood Center   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CD4 ANTIGEN; DNA POLYMERASE; GENE PRODUCT; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

APHERESIS; ARTICLE; BLOOD; BLOOD FILTRATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GRANULOCYTE; HUMAN; HUMAN CYTOMEGALOVIRUS; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOCYTE; VIRUS GENOME;

EID: 0035383781     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.11.3640     Document Type: Article

References (32)

1. Hillyer CD, Snydman DR, Berkman EM. The risk of cytomegalovirus infection in solid organ and bone marrow transplant recipients: transfusion of blood products. Transfusion. 1990;30:659-666.
2. Tegtmeier GE. Transfusion-transmitted cytomegalovirus infections: significance and control. Vox Sang. 1986;51(suppl 1):22-30.
3. Bowden RA, Sayers M, Flournoy N, et al. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med. 1986;314:1006-1010.
4. Dankner WM, McCutchan JA, Richman DD, et al. Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J Infect Dis. 1990;161:31-36.
5. De Witte T, Schattenberg A, Van Dijk BA, et al. Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened blood bank donors. Transplantation. 1990;50:964-968.
6. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood. 1995;86: 3598-3603.
7. Sawyer S, Elfath M, Whitley P, McNeil D, et al. Evaluation of the Leukotrap RC-PL in-line filter with a 500 mL blood volume. Transfusion. 1996; 36:8S.
8. Adams MR, Dumont LJ, McCall M, Heaton WA. Clinical trial and local process evaluation of an apheresis system for preparation of white cell-reduced platelet components. Transfusion. 1998; 38:966-974.
9. Sowemimo-Coker SO, Kim A, Tribble E, Brandwein HJ, Wenz B. White cell subsets in apheresis and filtered platelet concentrates. Transfusion. 1998;38:650-657.
10. Sawyer S, Elfath M, Whitley P, et al. Evaluation of the Leukotrap RC-PL in-line filter with a 500 mL blood volume. Transfusion. 1996;36:8S.
11. Fournel JJ, Zingsem J, Riggert J, et al. A multicenter evaluation of the routine use of a new white cell-reduction apheresis system for collection of platelets. Transfusion. 1997;37:487-492.
12. Dumont LJ, Dumont DF. Enhanced flow cytometric method for counting very low numbers of white cells in platelet products. Cytometry. 1996;26: 311-316.
13. Maniatis T, Sambrook J, Fritsch EF. Molecular Cloning: A Laboratory Manual. 2nd ed. Plainview, NY: Cold Spring Harbor Laboratory Press; 1989.
14. Dumont LJ, Dzik WH, Rebulla P, Brandwein H. Practical guidelines for process validation and process control of white cell-reduced blood components: report of the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT). Transfusion. 1996;36:11-20.
15. Bitsch A, Kirchner H, Dupke R, Bein G. Failure to detect human cytomegalovirus DNA in peripheral blood leukocytes of healthy blood donors by the polymerase chain reaction. Transfusion. 1992;32: 612-617.
16. Urushibara N, Kwon KW, Takahashi TA, Sekiguchi S. Human cytomegalovirus DNA is not detectable with nested double polymerase chain reaction in health blood donors. Vox Sang. 1995;68:9-14.
17. Smith KL, Kulski JK, Cobain T, Dunstan RA. Detection of cytomegalovirus in blood donors by the polymerase chain reaction. Transfusion. 1993;33: 497-503.
18. Krajden M, Shankaran P, Bourke C, Lau W. Detection of cytomegalovirus in blood donors by PCR using the digene SHARP signal system assay: effects of sample preparation and detection methodology. J Clin Microbiol. 1996;34:29-33.
19. Larsson S, Soderberg-Naucler C, Wang FZ, Moller. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative health blood donors over time. Transfusion. 1998;38:271-278.
20. Hahn G, Jores R, Mocarski ES. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A. 1998;95:3937-3942.
21. Taylor-Weideman J, Sissons P, Sinclair J. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol. 1994;68:1597-1604.
22. Soderberg-Naucler C, Fish KN, Nelson JA. Reactivation of lalent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell. 1997;91:119-126.
23. Tamura K, Ohsawa K, Koji T, et al. Allogeneic immune responses augment rat cytomegalovirus replication in rats. Transpl Proc. 1999;31:1376-1377.
24. Humar A, St Louis P, Mazzulli T, et al. Elevated serum cytokines are associated with cytomegalovirus and disease in bone marrow transplant recipients. J Infect Dis. 1999;179:484-488.
25. Asanuma H, Numazaki K, Nagata N, Chiba S. Cytokine response and polymerase chain reaction study of peripheral blood mononuclear cells in infants with human cytomegalovirus infection. FEMS Immunol Med Microbiol. 1995;12:153-158.
26. Larsson S, Soderberg-Naucler C, Wang FZ, Moller. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative health blood donors over time. Transfusion. 1998;38:271-278.
27. Taylor-Wiedman J, Sissons JG, Borysiewicz LK, et al. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol. 1991;72:2059-2064.
28. Preiksaitis JK. The cytomegalovirus-"safe" blood product: is leukoreduction equivalent to antibody screening? Transfus Med Rev. 2000;14:112-136.
29. Triulzi DJ, Meyer EM, Donnenberg AD. WBC subset analysis of WBC-reduced platelet components. Transfusion. 2000;40:771-780.
30. Johnson RJ, Bijay GS, Kastrup L. Apheresis platelet concentrates (PC) with low levels of WBC do not accumulate cytokines. Transfusion. 1997; 37:10S.
31. Hahn G, Jores R, Mocarski ES. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A. 1998;95:3937-3942.
32. + cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood 93;1999:394-398.